APA (7th ed.) Citation

JE, M., S, E., B, C., EÁ, R., A, P., M, F., & B, T. (2024). Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: The LEMVIDA study. Journal of patient-reported outcomes, 8(1), 148. https://doi.org/10.1186/s41687-024-00822-9

Chicago Style (17th ed.) Citation

JE, Meca-Lallana, Eichau S, Casanova B, Rodríguez EÁ, Pato A, Forner M, and Toledo B. "Improvements in Quality of Life of Patients with Multiple Sclerosis Receiving Alemtuzumab in Clinical Practice: The LEMVIDA Study." Journal of Patient-reported Outcomes 8, no. 1 (2024): 148. https://doi.org/10.1186/s41687-024-00822-9.

MLA (9th ed.) Citation

JE, Meca-Lallana, et al. "Improvements in Quality of Life of Patients with Multiple Sclerosis Receiving Alemtuzumab in Clinical Practice: The LEMVIDA Study." Journal of Patient-reported Outcomes, vol. 8, no. 1, 2024, p. 148, https://doi.org/10.1186/s41687-024-00822-9.